The Pistoia Alliance is pleased to invite you to an online roundtable discussion titled “AI and AI Agents in ELN and LIMS Workflows,” led by Yusuke Sato of Kyowa Kirin. This session will explore the latest trends and practical applications of AI in research and development environments, with opportunities to exchange insights and perspectives with […]
The Next Bottleneck in AI-Driven Small Molecule Discovery AI Is Advancing Rapidly in Drug Discovery — But Is Your Data Ready? Join leading experts from AI-first biotech, computational chemistry, and pharmaceutical R&D as they discuss how transforming fragmented scientific data into AI-ready intelligence is accelerating modern small molecule discovery workflows. Why AI-Driven Small […]
Agentic AI — systems capable of autonomous planning, tool use, and multi-step reasoning — represents one of the most transformative and potentially disruptive shifts in the AI landscape. For life sciences, the implications are profound: from automated literature review and hypothesis generation to end-to-end orchestration of research workflows. This two-hour seminar brings together technical […]
The IDMP Ontology has entered a new phase defined by long-term stewardship, governed quarterly releases, and a growing community of implementers. Join us for this Community of Interest webinar to hear directly from the team shaping IDMP-O’s future: where it stands today, how it’s being used in practice, and how you can get involved. As […]
Regulatory compliance remains one of the most significant barriers to the confident adoption of AI in pharmaceutical development. From GxP validation requirements to the evolving guidance from the FDA, EMA, and other authorities, organisations face a complex and shifting landscape that demands both technical rigour and regulatory expertise. This round table convenes regulatory affairs […]
This end-of-summer seminar takes a longitudinal view of AI across the full drug development pipeline — from the earliest stages of target identification and validation through to clinical trial design and execution. Through in-depth case studies and expert presentations, participants will examine where AI is delivering genuine, measurable value and where significant challenges remain. […]
